FCX Volume Alert - FCX 28.34 Freeport-Mcmoran Inc. $FCX Hit

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
FCX Volume Alert - FCX 28.34 Freeport-Mcmoran Inc. $FCX Hit a high of 28.39 Currently 11/07/14 Last price 28.34 +0.77 +2.79% With a day low of 27.75 and a current volume of 14,365,800.

FCX Freeport-Mcmoran Inc. Recent Headline News

Look for Shares of Freeport-McMoRan to Potentially Rebound after Yesterday's 2.37% Sell Off
Comtex SmarTrend(R) - Wed Nov 05, 3:59PM CST
Freeport-McMoRan (NYSE:FCX) traded in a range yesterday that spanned from a low of $27.10 to a high of $27.82. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $27.60 on volume of 15.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
FCX: 28.34 (+0.77)

Will Commodity Prices Drag Down Apache (APA) Q3 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 2:50PM CST
Domestic oil and gas explorer Apache Corp. (APA) is set to release its third-quarter 2014 results before the opening bell on Thursday, Nov 6.
CPG: 32.53 (+0.94), FCX: 28.34 (+0.77), APA: 76.52 (+1.08), ROYT: 9.88 (+0.16)

Freeport-McMoRan Down 25.5% Since SmarTrend Downtrend Call (FCX)
Comtex SmarTrend(R) - Wed Nov 05, 11:04AM CST
SmarTrend identified a Downtrend for Freeport-McMoRan (NYSE:FCX) on August 1st, 2014 at $36.95. In approximately 3 months, Freeport-McMoRan has returned 25.54% as of today's recent price of $27.51.
FCX: 28.34 (+0.77)

Freeport-McMoRan (FCX) Approaches New Downside Target of $27.30
Comtex SmarTrend(R) - Wed Nov 05, 8:58AM CST
Freeport-McMoRan (NYSE:FCX) has opened bearishly below the pivot of $27.84 today and has reached the first level of support at $27.55. Analysts will be watching for a cross of the next downside pivot targets of $27.30 and $26.76.
FCX: 28.34 (+0.77)

Freeport Wraps Up Sale of Candelaria Mine Stake for $1.8B - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 5:20PM CST
Freeport-McMoRan Inc. (FCX) said that it has completed the sale of its 80% stake in the Candelaria/Ojos del Salado copper mining operation and supporting infrastructure in Chile to Lundin Mining Corporation for $1.8 billion in cash.
UUUU: 7.00 (+0.15), FCX: 28.34 (+0.77), XPL: 0.97 (unch), TC: 2.00 (+0.23)

Stock Market News for November 04, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 9:10AM CST
Drop in crude prices to over two-year low negated benchmarks’ momentary gains yesterday and they ended almost flat
STLD: 22.48 (+0.33), FCX: 28.34 (+0.77), COP: 72.16 (+0.84), XOM: 96.59 (+0.33), AKS: 6.62 (+0.48), BP: 42.06 (+0.19), MRO: 34.39 (+0.05), CVX: 118.80 (+0.27), X: 37.57 (+1.47)

Freeport-McMoRan Completes Sale of Its Interests in Candelaria/Ojos for $1.8 Billion in Cash
Business Wire - Mon Nov 03, 2:00PM CST
Freeport-McMoRan Inc. (NYSE: FCX) announced today that it has completed its previously announced sale of its 80 percent ownership interest in the Candelaria/Ojos del Salado copper mining operations and supporting infrastructure to Lundin Mining Corporation (TSX:LUN) (Nasdaq OMX:LUMI) for cash consideration of $1.8 billion, before closing adjustments. The transaction has an effective date of June 30, 2014.
FCX: 28.34 (+0.77), LUN.TO: 5.40 (+0.28)

Upcoming Conference, Award, Financial Results, and Technical Update - Research Reports on LyondellBasell, DuPont, Freeport-McMoRan, Williams and EOG
PR Newswire - Mon Nov 03, 7:45AM CST
Today, Analysts Review released its research reports regarding LyondellBasell Industries N.V. (NYSE: LYB), E. I. du Pont de Nemours and Company (NYSE: DD), Freeport-McMoRan Inc. (NYSE: FCX), Williams Companies, Inc. (NYSE: WMB) and EOG Resources, Inc. (NYSE: EOG). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7631-100free.
LYB: 87.46 (+1.16), FCX: 28.34 (+0.77), EOG: 99.55 (+0.58), DD: 70.41 (+0.29), WMB: 55.38 (+0.67), MS: 35.66 (+0.35)

Biloxi Marsh Lands Corporation Announces Unaudited Results for the Third Quarter and First Nine Months of 2014 and Provides Update
Business Wire - Fri Oct 31, 12:03PM CDT
Biloxi Marsh Lands Corporation (PINK SHEETS: BLMC) today announces its unaudited results for the third quarter of 2014 and first nine months of 2014 and provides update. The Company's revenue for the three months ending September 30, 2014 from oil and gas production for its fee lands was $128,999 compared to revenue of $133,407 for the third quarter of 2013. For the first nine months of 2014, revenue generated from the Company's fee lands decreased to $353,227 from $453,316 for the same period in 2013.
FCX: 28.34 (+0.77)

Will Freeport-McMoRan (FCX) Stock Be Helped Today After Indonesian Strike Averted?
at The Street - Fri Oct 31, 9:02AM CDT
The company escaped a one-month strike when workers at the natural resources company's Indonesian copper mine called it off.
FCX: 28.34 (+0.77)

Watch for Shares of Freeport-McMoRan (FCX) to Approach Support at $28.32
Comtex SmarTrend(R) - Thu Oct 30, 11:41AM CDT
Shares of Freeport-McMoRan (NYSE:FCX) opened today below their pivot of $29.03 and have already reached the first level of support at $28.66. Investors may be interested in a cross of the next downside pivot targets of $28.32 and $27.61.
FCX: 28.34 (+0.77)

Freeport-McMoRan Shares Down 21.5% Since SmarTrend's Sell Call (FCX)
Comtex SmarTrend(R) - Wed Oct 29, 9:44AM CDT
SmarTrend identified a Downtrend for Freeport-McMoRan (NYSE:FCX) on August 1st, 2014 at $36.95. In approximately 3 months, Freeport-McMoRan has returned 21.50% as of today's recent price of $29.00.
FCX: 28.34 (+0.77)

Freeport-McMoRan (FCX) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Wed Oct 29, 9:06AM CDT
The following Freeport-McMoRan (FCX) conference call took place on October 28, 2014, 10:00 AM ET. This is a transcript of that earnings call:
FCX: 28.34 (+0.77)

'Fast Money' Recap: Facebook Expenses Overshadows Great Earnings
at The Street - Wed Oct 29, 4:00AM CDT
The trading panel discussed Facebook and other companies reporting earnings including U.S. Steel and Panera Bread.
HYG: 92.34 (+0.09), EA: 40.94 (+0.14), PNRA: 168.29 (+1.00), FB: 75.60 (+0.34), NNA: 3.01 (+0.06), FCX: 28.34 (+0.77), HIG: 40.20 (+0.29), YHOO: 48.55 (+0.62), GILD: 106.45 (-0.49), CMG: 649.03 (+1.91), NDLS: 24.82 (-0.93), LOCO: 36.60 (-0.70), TWTR: 40.31 (-0.53), X: 37.57 (+1.47), AAPL: 109.01 (+0.31), APC: 94.31 (+0.80), BABA: 114.56 (+2.99)

Why Shares of Freeport-McMoRan Plunged Today
Travis Hoium, The Motley Fool - Motley Fool - Tue Oct 28, 3:22PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of miner Freeport-McMoRan Inc   fell as much...
FCX: 28.34 (+0.77)

Freeport (FCX) Beats Earnings, Revenue Estimates in Q3 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 9:53AM CDT
Freeport-McMoRan Inc. (FCX) reported earnings of 53 cents per share for third-quarter 2014, reflecting a decline of 32.9% from the year ago earnings of 79 cents.
UUUU: 7.00 (+0.15), AA: 16.33 (-0.04), FCX: 28.34 (+0.77), TC: 2.00 (+0.23)

Unusual Social Activity Around Freeport-McMoRan (FCX) Today
at The Street - Tue Oct 28, 9:15AM CDT
Trade-Ideas LLC identified Freeport-McMoRan (FCX) as an unusual social activity candidate
FCX: 28.34 (+0.77)

Freeport-McMoRan (FCX) Stock Down Today After Third-Quarter Profit Drop
at The Street - Tue Oct 28, 8:37AM CDT
Freeport-McMoRan (FCX) is falling Tuesday after reporting a 32% drop in third-quarter earnings.
FCX: 28.34 (+0.77)

Freeport-McMoRan Inc (FCX) Downgraded From Buy to Hold
at The Street - Tue Oct 28, 8:33AM CDT
Freeport-McMoRan Inc (FCX) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C.
FCX: 28.34 (+0.77)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 269

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
China's 15th Plan: Key Moves in the Capital Markets

Updated Category News Views 127

Riding the Waves of Reform in China The winds of change are blowing through China's capital markets, and Guosen Securities is putting a stake in the ground with bold priorities for the 15th Five-Year Plan. As far as I'm concerned, the headlines here are thick with implications for anyone eyeing a piece of China's economic pie from 2026–2030. The Pillars of Stability and...

Continue Reading
CStone's CS2009: A Leap in Cancer Treatment Validated

Updated Category News Views 59

CStone's Game-Changer: CS2009 in the Spotlight CStone Pharmaceuticals just pulled a rabbit out of a hat at the ESMO 2026 Congress, showcasing the clinical might of their CS2009. This ain't just another hype train, folks. We're talking about a trispecific antibody targeting PD-1, VEGF, and CTLA-4. With data rolled out from over 300 patients, this compound promises a...

Continue Reading
NOTHING NINE's Global Ambitions: Paris Show's Impact

Updated Category News Views 83

Paris: Stage or Launchpad? You’d think walking that catwalk in Paris is the holy grail—fashion's own illustrious red carpet. But when you're Chloe, founder of NOTHING NINE, the real hustle kicks off once the lights dim. On 29th September 2026, this designer brand strutted its stuff at one of the grandest venues, Les Invalides, part of the prestigious Paris Fashion...

Continue Reading
Ambient AI Shows Promise for Boosting Cancer Care Efficiency

Updated Category News Views 13

Study Points to Ambient AI's Promise in Oncology Some days, the world of cancer care is a real beast to tackle. But today, we've got a glimpse into how technology, and specifically ambient AI, might just help slay some of the burdens that these healthcare warriors face daily. The Florida Cancer Specialists & Research Institute (FCS) joined hands to dive into how this tech...

Continue Reading
Superteam Wheels Rides Into Spain with RACEIT Deal

Updated Category News Views 63

Rolling Out the Red Carpet for Spanish Cyclists Think of it as the pedal-powered bridge from wherever Superteam Wheels calls home to the sunny streets of Spain. If you're in the cycling game, this new partnership between Superteam Wheels and COMERTECH RACEIT, S.L., better known as RACEIT, is drawing a line in the sand—or perhaps on the asphalt—across Europe. Starting...

Continue Reading
Zinzino Eyes European Market With New Botanical Line

Updated Category News Views 98

Zinzino's Strategic Play in Europe's Wellness Market There's a new player on the European wellness block, and it's Zinzino's latest concoction of fermented botanical supplements. This isn't just your run-of-the-mill vitamin shop stock; we're talking about a lineup crafted for distinct parts of the day, reflecting an evolving consumer trend. People are looking for tailored...

Continue Reading
HCLTech Partners with Rapidus on Semiconductor Future

Updated Category News Views 81

Making Sense of the HCLTech and Rapidus Collaboration When you're talking about the world of semiconductors, no two words get tossed around more than innovation and speed. Now, with the recent partnership between HCLTech and Rapidus, those words are bound to echo from India to Japan and beyond. We have HCLTech, a stalwart of global technology, teaming up with Rapidus, a...

Continue Reading
ASICS and University of Michigan Launch Innovation Lab

Updated Category News Views 88

Running Innovation Gets a Boost in Ann Arbor On a crisp fall day up in Ann Arbor, ASICS and the University of Michigan have decided it's high time to shake up the world of running product R&D. These two powerhouses just launched the ASICSx Michigan Sport Innovation Center (AMSI), an academic-industry research lab. It's like they're mixing college smarts with business...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 412

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

DXC Technology to Announce Q3 Fiscal 2026 Earnings Soon

Updated Category News Views 159

DXC Technology Announces Upcoming Q3 Fiscal 2026 Earnings DXC Technology (NYSE: DXC), a prominent leader in enterprise technology and innovation, has set a date for the release of its financial results for the third quarter of fiscal 2026. The earnings report will be published on a Thursday, after the market closes, providing stakeholders with insights into the company's...

Continue Reading
Jim Cramer Highlights Mettler-Toledo as a Buy Amid Market Woes

Updated Category News Views 188

Jim Cramer Recommends Mettler-Toledo International Inc. On a recent episode of CNBC's popular program, Jim Cramer advised investors to consider buying shares of Mettler-Toledo International Inc. (NYSE: MTD). Cramer's endorsement came after the company reported impressive quarterly results, showcasing strong financial health. Strong Earnings Report from Mettler-Toledo...

Continue Reading
Strategic Alliance Between Vireo and Curio Enhances Growth Opportunities

Updated Category News Views 110

Strategic Partnership Announced Leading cannabis companies Vireo Growth Inc. and Curio Wellness have forged a partnership aimed at leveraging shared resources to tap into the burgeoning cannabis market. This collaboration marks an exciting new chapter for both companies as they work to introduce innovative health and wellness products to consumers. Vireo Growth Inc.: A...

Continue Reading
Anoto Group Reports Second Quarter Results 2024

Updated Category News Views 137

Overview of the Interim Report for 2024 The interim report covering January to June 2024 provides important insights into Anoto Group AB's operations and financial health. Anoto Group continues to be a leader in technology, particularly in optical recognition and digital writing. This report emphasizes key financial metrics and the company's strategic initiatives in a...

Continue Reading
AAOS: Orthobiologics' Future Anchored in Solid Science

Updated Category News Views 9

The Challenge of Orthobiologics: Hype vs. Science Amid the buzz around orthobiologics, it's high time folks face reality: enthusiasm doesn't equal evidence. Dr. Jason Dragoo, the symposium co-chair, hit the nail right on the head—the medical community's chief duty is to sift the wheat from the chaff when it comes to flashy new treatments that lack scientific backing....

Continue Reading